The LPN/LVN is assisting in the care of a patient with metastatic cancer. The patient expresses feelings of hopelessness and frustration over the unavailability of effective medical therapy in the United States. Which information would the LPN/LVN provide to the patient regarding approval of drugs in the United states?

A. “You can receive the drug in a clinical trial.” Clinical trials offer patients access to new treatments that are not yet widely available. This is a valid option for patients seeking treatments not yet approved by the FDA. B. “I understand your frustration, have you thought of traveling to another country for the medication.” This is not an appropriate response. It doesn't provide information on the FDA approval process and may suggest that the patient should bypass U.S. regulations. C. “Have you considered using herbal remedies.” While herbal remedies may offer some benefits, they are not a substitute for FDA-approved treatments, especially for a condition as serious as metastatic cancer. D. “The FDA requires drugs to be scientifically researched and this can take up to 8 years.” This is accurate information. The FDA's approval process is rigorous and includes multiple phases of research to ensure a drug's safety and efficacy.